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Neuronal hyperexcitability is a phenomenon associated with early Alzheimer’s disease.The underlying mechanism is considered to
involve excessive activation of glutamate receptors; however, the exact molecular pathway remains to be determined. Extracellular
recording from the CA1 of hippocampal slices is a long-standing standard for a range of studies both in basic research and in
neuropharmacology. Evoked field potentials (fEPSPs) are regarded as the input, while spiking rate is regarded as the output of
the neuronal network; however, the relationship between these two phenomena is not fully clear. We investigated the relationship
between spontaneous spiking and evoked fEPSPs using mouse hippocampal slices. Blocking AMPA receptors (AMPARs) with
CNQX abolished fEPSPs, but left firing rate unchanged. NMDA receptor (NMDAR) blockade with MK801 decreased neuronal
spiking dose dependently without altering fEPSPs. Activating NMDARs by small concentration of NMDA induced a trend of
increased firing. These results suggest that fEPSPs are mediated by synaptic activation of AMPARs, while spontaneous firing is
regulated by the activation of extrasynaptic NMDARs. Synaptotoxic Abeta(1-42) increased firing activity withoutmodifying evoked
fEPSPs. This hyperexcitation was prevented by ifenprodil, an antagonist of the NR2B NMDARs. Overall, these results suggest that
Abeta(1-42) induced neuronal overactivity is not dependent on AMPARs but requires NR2B.
1. Introduction
Extracellular recording from hippocampal slices has long
been a method of choice for determining the changes in
excitability and synaptic plasticity of the CA1 microcircuitry
[1]. Spontaneous spikes and, far more often, field excitatory
postsynaptic potentials (fEPSPs) are recorded extracellularly
from a local network of neurons; however, the relationship
between these two phenomena is not fully clear. Intuitively,
both electrophysiological events correlate with the excitabil-
ity of the network under investigation, but these events are
generated by different mechanisms. Field EPSPs are mainly
composed of subthreshold events from a population of neu-
rons, like dendritic depolarizations [2] and glial contributions
to the net extracellular charge-flow, arising mainly from the
function of transporters [3, 4]. In contrast, spontaneous firing
represents only neuronal suprathreshold events [5]. Another
difference is that a fEPSP is evoked by a stimulus, and
therefore it is the result of a coordinated and synchronized
electrical activity of a cell population, mediated by synaptic
connections. Spontaneous spikes, in contrast, are not evoked
by an external stimulus, and they are more likely to be
dependent on intrinsic network connections and properties
[6].
N-Methyl-D-aspartate receptor (NMDAR) and 𝛼-Ami-
no-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPAR) play a key role in generating rapid excitatory events
in the CA1, but these receptors serve different purposes.Their
relative contribution to fEPSPs is well described [7]; however,
their involvement in spontaneous spike-generation remains
unknown and data on the correlation of extracellularly
recorded field responses and action potentials are scarce.
Activation of glutamate (Glu) receptors is known to play
an important role in the mechanisms of neuronal plasticity
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that might be the cellular basis of learning and memory
[8]. Several studies have shown that the synaptic plasticity is
impaired in Alzheimer’s disease (AD) [9], the most common
form of neurodegenerative disease, characterized by the pres-
ence of insoluble amyloid deposits in the brain. Overwhelm-
ing evidence suggests that the main component of plaques,
amyloid-beta (Abeta) peptide, is thought to be responsible
for the synaptic and cellular pathology of AD (for review
see [10]). Numerous studies have reported that the severity
of AD strongly correlates with decreased synapse density in
hippocampus and cortex and with disruption of memory-
related synapse function. Literature data strongly support
the synaptotoxicity of Abeta(1-42), and the accumulation of
soluble Abeta(1-42) [11] in the brain of patients and animal
models of AD is associated with impairments of cognition
and memory [12–14]. Recently, Abeta(1-42) was shown to
induce epileptiform activity, both in vitro [15] and in vivo,
and transgenic mice overexpressing Abeta develop seizures
over time [16]. Moreover, AD patients have an estimated
87 times higher probability of developing epileptic seizures
compared to age-matched population [17]. Despite the recent
advancement in the research of the pathomechanisms of
AD, the exact mechanism by which neuronal overactivity
develops is unknown.
Recent findings suggest that Abeta blocks neuronal gluta-
mate (Glu) uptake at synapses, leading to increased Glu level
at the synaptic cleft [18]. Increased brain extracellularGlu, but
not 𝛾-aminobutyric acid (GABA), concentration was found
upon Abeta administration by use of microdialysis technique
[19, 20]. A resultant rise in Glu levels would lead to a spillover
and activation of extra- or perisynapticNMDARs enriched in
the B isoform of the NMDAR 2 subunit (NR2B), which play
a major role in the induction of long-term depression (LTD)
[21] and have also been shown to help mediate the inhibition
of long-term potentiation (LTP) by soluble Abeta oligomers
[22].
In this study we investigated the mechanisms by which
fEPSPs and spontaneous firing are regulated in the CA1 of
hippocampal slices.We confirmed that fEPSP, but not spiking
activity, is mainly mediated by AMPARs. In contrast, spon-
taneous activity is regulated by NMDARs. Bath application
of synaptotoxic Abeta(1-42) greatly enhanced spontaneous
firing rate, which could be prevented by blocking NR2B
subunits.
2. Experimental Procedures
2.1. Compounds. For the preparation of artificial cere-bro-
spinal fluid (ACSF), all salts, glucose, 6-cyano-7-nitroquin-
oxaline-2,3-dione (CNQX), (+)-MK-801 hydrogen male-
ate, and 𝛼-(4-Hydroxyphenyl)-𝛽-methyl-4-benzyl-1-piperi-
dineethanol (+)-tartrate salt (ifenprodil) were purchased
from Sigma-Aldrich (St. Louis, MO).
2.2. Animals. The study conformed to EU Directive
2010/63/EU and was approved by the regional Station for
Animal Health and Food Control under Project License
XVI/8/2013. BALB/c mice were housed in groups of 2-3
under standard conditions (24∘C, 12 h light-dark cycle) with
food and water available ad libitum.
2.3. Ex Vivo Electrophysiology. Hippocampal slices of 400 𝜇m
in thickness were prepared from the brains of 3-month-
old mice using a standard protocol [23]. Briefly, slices were
incubated in artificial cerebrospinal fluid ACSF gassed with
95%O
2
and 5%CO
2
at 35∘C for 60min. ACSF was composed
of (in mM) 130 NaCl, 3.5 KCl, 3 CaCl
2
, 1.5 MgSO
4
, 0.96
NaH
2
PO
4
, 24 NaHCO
3
, and 10 D-glucose, pH 7.4. Individual
slices were transferred to a 3D-MEA chip with 60 tip-shaped
and 60𝜇m high electrodes spaced by 200𝜇m (Qwane Bio-
sciences, Lausanne, Switzerland). The surrounding solution
was quickly removed, and the slice was immobilized by
placing a grid onto it. The slice was continuously perfused
with oxygenated ACSF (3mL/min at 36∘C) throughout the
entire recording session. Unfiltered data were recorded using
a standard, commercially available MEA 60 setup (Multi
Channel Systems MCS GmbH, Reutlingen, Germany). Field
EPSPs were recorded from the proximal stratum radiatum
at 5 kHz, while spontaneous spiking activity was recorded
from the CA1 stratum pyramidale at a frequency of 25 kHz
for 5min epochs. For analyzing and sorting the spiking activ-
ity, Spike2 software package (Cambridge Electronic Design,
Cambridge, UK) was used. Recordings were filtered between
300 and 3000Hz offline, and the threshold for spike detection
was 2.5 fold higher than the noise level. The data of those
electrodes were included in the analysis where the initial
spiking activity was above 0.5Hz. Firing activity ranged from
150 to 1000 spikes/5min. Data are considered as multiunit
activity.
2.3.1. Stimulation Protocol. TheSchaffer-collateral was stimu-
lated by injecting a biphasic voltage waveform (−100/+100 𝜇s)
through one selected electrode at 0.033Hz. Care was taken to
place the stimulating electrode in the same region at every
slice. The peak-to-peak amplitudes of fEPSPs at the proximal
stratum radiatum of CA1 were analyzed. After a 30min
incubation period, the threshold and maximum stimulation
intensities for evoked responses were determined. To evoke
responses, 30% of the maximal stimulation intensity was
used. The level of LTP (the last 10 peak-to-peak amplitudes)
was compared to the average of the last 20 peak-to-peak
amplitudes of evoked fEPSPs before applying theta-burst
stimulation (TBS). TBS comprised of 15 bursts given at 5Hz
and individual burst contained 4 pulses given at 100Hz per
burst.
2.3.2. Drug Treatments. All slices were incubated for 30min
without stimulation in the recording chamber before any
recording was done. Following the first spike-recording,
slices were left to incubate a further 60min with contin-
uous fEPSP recording and then slices were treated with
10 𝜇M CNQX or 10 𝜇M MK801 or 25 𝜇M MK801 or ACSF
containing low concentration of Mg
2
SO
4
(low Mg2+ ACSF;
0.25mM) or 0.5 𝜇M NMDA or 0.05 𝜇M AMPA for 30min
(see Figure 1(c)). Spontaneous activity was recorded before
and 30min after treatment for 5min and the spiking data
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Figure 1: Exemplar recordings and the timeline of the experiments. Both evoked fEPSPs and spiking activity recording electrodes were
located in the CA1 region of mouse hippocampal slice.The fEPSPs were recorded from the stratum radiatum (a) and the spontaneous spiking
was recorded from the stratum pyramidale (b). Both fEPSPs and spiking activity were recorded from the same slice. Data were considered as
multiunit activity. (c) shows the timeline of the recordings. The initial spiking activity (recorded at 0 h) was considered as 100% in each slice.
was compared to the untreated group recorded at the same
time point. Other cohorts of slices were treated with 1𝜇M
oligomer Abeta(1-42), ifenprodil (3 𝜇M), and ifenprodil +
Abeta(1-42) for 2.5 h. The spiking activity was recorded at
every 30min for 5min. The effect of CNQX was also tested
in lowMg
2
SO
4
-containingACSF (0.25mM), wheremodified
ACSF was perfused to the slices from the beginning of
the experiment. Electric stimulation was stopped during
spontaneous activity recordings. Spiking frequency of each
slice (number of spikes) was normalized to the initial firing
activity (following the first 30min incubation; 0 h), which
was taken as 100% in all channels. Following this, slices were
treated with 1 𝜇M oligomer Abeta(1-42) for 60min and then
LTP was induced by the TBS protocol. LTP was followed
for 90min after TBS. During treatment, evoked fEPSPs were
recorded.
2.4. Synthesis and Characterization of Abeta(1-42). Detailed
description of the synthesis and characterization of Abeta(1-
42) is reported in [23, 24]. Briefly, a depsipeptide derivative
of Abeta(1-42) was synthesized and, after purification, it
was used in lyophilized form. A 200𝜇M stock solution
of the peptide was prepared in 0.1mM NaOH, and the
pH was set to 11.0. After incubation for 2 h at ambient
temperature, the stock solution was diluted into ACSF to
a concentration of 50𝜇M and the pH was set to 7.3. The
peptide solution was incubated for 12 h at 37∘C and, prior
to use, it was diluted with ACSF to a final concentration
of 1 𝜇M. Aggregation grade and the size distribution of the
oligomers were checked by Western blots by following the
methods described in [23]. Oligomers were detected either
with sequence-specific BAM10 antibody (Sigma-Aldrich) or
with conformation specific OC antibody (Millipore), which
detects the oligomers of fibrillar nature, that is, with beta sheet
structure.
2.5. Statistics
2.5.1. Statistical Analysis for fEPSPs. Testing for normal-
ity was done with the Kolmogorov-Smirnov normality
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Figure 2: AMPA receptorsmediate fEPSPs but not spontaneous activity. BlockingAMPARs abolished fEPSPs (a). Bar graphs show the average
of the fEPSPs amplitudes of the 25–30min period after treatment. CNQX induced a complete reduction of evoked fEPSPs (𝑛 = 5, 𝑃 < 0.001)
(b); however the spiking activity was not affected (c). Inset at the right panel shows representative fEPSPs before (grey) and after (black)
treatment and representative spike trains. Error bars show SEM; ∗∗∗𝑃 ≤ 0.001.
test. Our data have shown normal distribution; hence,
independent-samples 𝑡-test and one-way repeated measures
analysis of variance (ANOVA) were used with the Bonferroni
test for post hoc analysis. The 𝑃 value ≤ 0.05 was considered
significant in all cases. Data were analyzed using SPSS
statistical software.
2.5.2. Statistical Analysis for Spiking Rate. Kolmogorov-
Smirnov test was used also for testing normality of these
data. Since our data have shown nonparametric distribution,
we used nonparametric tests (Kruskal-Wallis test was fol-
lowed by Mann-Whitney 𝑈 test) for determining differences
between two and several groups. Data were analyzed using
SPSS. 𝑃 value of ≤ 0.05 was considered significant in all cases.
3. Results
3.1. Field EPSPs, but Not Spontaneous Spikes, Are Mediated by
AMPARs. We recorded fEPSPs from the stratum radiatum
(Figure 1(a)) and in parallel spontaneous spikes from the
stratum pyramidale (Figure 1(b)) of the CA1. Both fEPSPs
and spontaneous activity could be abolished by application
of 1 𝜇M tetrodotoxin (data not shown).
First, we investigated the contribution of AMPARs to
evoked fEPSPs and spontaneous activity, using CNQX, an
AMPAR inhibitor. Blocking AMPARs resulted in a complete
reduction of evoked fEPSPs (untreated: 𝑛 = 5; 98.84 ± 2.41%
versus CNQX: 𝑛 = 5; 4.62 ± 0.45%, 𝑃 = 0.001, inde-
pendent samples 𝑡-test; Figures 2(a) and 2(b)). Conversely,
spiking activity remained unchanged (untreated: 𝑛 = 5;
139.55 ± 44.95% versus CNQX: 𝑛 = 5; 182.18 ± 56.76%,
Neural Plasticity 5
0 10 20 30
50
100
150
Untreated
fE
PS
Ps
 am
pl
itu
de
 (%
 o
f c
on
tro
l)
Time (min)
−10
MK801 (25 𝜇M)
MK801 (10 𝜇M) Low Mg2+ACSF (0.25 mM)
Untreated
0
20
40
60
80
100
120
fE
PS
Ps
 am
pl
itu
de
 (%
 o
f c
on
tro
l)
MK801
(25 𝜇M)
MK801
(10 𝜇M)
Low Mg2+
ACSF (0.25 mM)
0
100
200
300
400
N
um
be
r o
f s
pi
ke
s (
%
 o
f c
on
tro
l)
Untreated
Untreated
MK801
(25 𝜇M)
MK801
(10 𝜇M)
Low Mg2+
ACSF (0.25 mM)
 (0.25 mM)
10ms 
1
m
V
∗∗
∗
MK801
(25 𝜇M)
MK801
(10 𝜇M)
After
MK801 (25 𝜇M)
Before 
MK801 (25 𝜇M)
Before 
Low Mg2+ACSF
2
0
𝜇
V
15 s
After
Low Mg2+ACSF
Mg2+
(a)
(c)(b)
Figure 3: NMDA receptors mediate spontaneous activity but not fEPSPs. Blocking (MK801) or enhancing (low-Mg2+ ACSF) NMDAR
function did not influence fEPSPs (a). Right panel shows representative fEPSPs before (grey) and after (black) treatment. Bar graphs show
the average of the fEPSPs amplitudes of the 25–30min period after treatment (b). In contrast, MK801 dose dependently reduced spiking
frequency and low Mg2+ ACSF enhanced firing rate (untreated versus MK801 in 25𝜇M: 𝑃 = 0.035 and untreated versus low Mg2+ ACSF:
𝑃 = 0.004) (c). Inset shows representative spike trains. Error bars show SEM; ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01.
Mann-Whitney𝑈 test; Figure 2(c)), suggesting that AMPARs
play a key role in generating fEPSPs but not spontaneous
spiking. Under physiological conditions, NMDARs activa-
tion is dependent on depolarization, for example, on previous
AMPARs activation. Thus we changed to low Mg2+ ACSF
(0.25mM) to remove the depolarization-dependent Mg2+
plug from the NMDAR. Applying 10 𝜇MCNQX to lowMg2+
ACSF slices for 30min, fEPSPs were completely blocked
(control: 𝑛 = 6; 95.54 ± 81% versus CNQX in low Mg2+-
containingACSF: 𝑛 = 6; 6.44±0.36%,𝑃 < 0.001, independent
samples 𝑡-test; see Supplementary Figure 1 available online at
http://dx.doi.org/10.1155/2014/584314). We have also tried to
activate AMPARs by applying a low concentration of AMPA
(0.05𝜇M), but we observed epileptiform field responses
and a huge increase of basal activity which hindered the
unambiguous detection of action potentials (Supplementary
Figure 2).
3.2. Spontaneous Firing, but Not fEPSP, Is Governed by
NMDARFunction. Next, we focused onNMDARs. Applying
an NMDAR antagonist, MK801 resulted in a dose-dependent
decrease of spiking rate (untreated: 𝑛 = 5; 139.55 ± 44.95%
versus MK801 in 10 𝜇M: 𝑛 = 5; 96.73%±32.22, 𝑃 = 0.48;
MK801 in 25 𝜇M: 𝑛 = 5; 29.23 ± 22.93, 𝑃 = 0.031, Mann-
Whitney 𝑈 test; Figure 3(c)). MK801 did not have any effect
on fEPSP in either 10 𝜇M or 25𝜇M (untreated: 𝑛 = 5;
98.8 ± 2.4% versus MK801 in 10 𝜇M: 𝑛 = 5; 101.23 ± 1.17%
versus MK801 in 25 𝜇M: 𝑛 = 5, 104.49 ± 1.72%; one-way
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Figure 4: Abeta(1-42) impairs LTP. Representative fEPSPs from both control and Abeta(1-42) groups. Field EPSP was recorded before (grey)
and 90min after LTP induction (control is in black and Abeta(1-42) is in red) from the proximal stratum radiatum of CA1 (see above).
Following 1 h of Abeta(1-42) treatment, LTPwas induced by TBS protocol. LTPwas reduced in Abeta(1-42) treated slices compared to controls
90min after TBS (untreated versus Abeta: 𝑃 = 0.002) (a).The amplitudes of fEPSPs after TBS were normalized to pre-TBS control. Bar graphs
show the average of the last 5min of LTP. Error bars represent SEM; ∗∗𝑃 ≤ 0.01 (b).
ANOVA and Bonferroni post hoc test; Figures 3(a) and 3(b)).
Another cohort of slices was treated with ACSF having
reduced Mg2+ concentration for 30min. We have observed
a massively elevated frequency of the spontaneous spiking
activity compared to the untreated slices (𝑛 = 7, 316.34 ±
41.89%, 𝑃 = 0.004, Mann-Whitney 𝑈 test; Figure 3(c)), but
evoked fEPSP responses remained unaltered (𝑛 = 7, 101.54 ±
1.69%, one-way ANOVA and Bonferroni post hoc test). Based
on these results we hypothesized that spontaneous firing
is mediated by the ambient Glu concentration acting on
the extrasynaptic NMDARs. Therefore we tried to activate
selectively this set of receptors by applying low concentration
of NMDA (0.5 𝜇M) in normal ACSF [25]. This treatment
resulted in unchanged fEPSPs (untreated: 𝑛 = 5; 98.8 ± 2.4%
versus NMDA: 𝑛 = 9; 94.03 ± 1.04%; independent-samples
𝑡-test) but induced a trend of elevated firing rate (untreated:
𝑛 = 5; 139.55±44.95%versus NMDA: 𝑛 = 9; 253.02±105.9%,
𝑃 = 0.51, Mann-Whitney 𝑈 test; Supplementary Figure 3).
3.3. Abeta(1-42) Impairs LTP. A major drawback of Abeta
studies is that the activity of various Abeta preparations
may vary between protocols and even between batches. We
verified the activity of Abeta batches we have used for this
study by determining their effect on CA1 LTP. Abeta(1-42)
was applied for 60min before inducing LTP by using TBS.
Untreated slices showed a robust and permanent elevation
of evoked fEPSPs after TBS (𝑛 = 7; 155.48 ± 7.16% 90min
after TBS), while slices having received Abeta(1-42) failed to
exhibit permanent LTP (𝑛 = 8; 122.54 ± 4.75% 90min after
TBS,𝑃 = 0.002, independent-samples 𝑡-test; Figures 4(a) and
4(b)).
3.4. Abeta(1-42) Induces Hyperexcitation via NR2B. Firing
rate was determined every 30min in 5min epochs within
the time frame of the recordings. In the untreated slices the
amplitude of fEPSPs increased slightly until 1.5 h reaching
103.36 ± 2.67% of the initial amplitude and then decreased
to initial value (𝑛 = 5; 0.5 h: 100.8±1.65%; 1 h: 102.9±1.84%;
2 h: 100.86±3.38%; and 2.5 h: 98.18±4.04%, one-way repeated
measures ANOVA and Bonferroni post hoc test; Figures 5(a)
and 5(b)). Similarly, spiking frequency did not change over
time (𝑛 = 5; 0.5 h: 124.34±29.72%; 1 h: 129.57±53.28%; 1.5 h:
139.55±44.95%; 2 h: 102.48±28.42; and 2.5 h: 76.16±28.08%,
Mann-Whitney 𝑈 test; Figure 6).
Abeta(1-42) applied in 1 𝜇M did not change fEPSPs
amplitudes (Abeta(1-42): 𝑛 = 7; 0.5 h: 107.08 ± 2.43%; 1 h:
106.41 ± 2.93%; 1.5 h: 103.54 ± 3.07%; 2 h: 100.92 ± 3.06%;
and 2.5 h: 97.1 ± 2.97% compared to untreated slices, see
above; Figure 5), suggesting that Abeta(1-42) did not affect
the AMPAR-mediated synaptic transmission. On the other
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Figure 5: Neither Abeta(1-42) nor ifenprodil affects fEPSPs. Representative fEPSPs are shown before (grey) and after treatment in the upper
panel. Neither Abeta(1-42) nor ifenprodil changed fEPSPs amplitudes (one-way repeated measures ANOVA with Bonferroni correction) (a).
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hand, Abeta(1-42) induced a massively elevated firing (𝑛 =
7; 0.5 h: 182.6 ± 30.91%; 1 h: 242.29 ± 83.31%, 𝑃 = 0.043;
1.5 h: 233.29 ± 83.31%; 2 h: 240.32 ± 85.0%, 𝑃 = 0.036;
and 2.5 h: 244.72 ± 64.21%, 𝑃 = 0.001, Mann-Whitney 𝑈
test; Figure 6) compared to untreated slices, suggesting that
NMDARs are involved in the effect of Abeta(1-42). Several
recent reports suggested that the deleterious effect of Abeta
is mediated via the NR2B subunit-containing NMDARs (see
Section 4). To test whether the observed hyperexcitation in
our experimental setup is sensitive to NR2B antagonism, we
have applied ifenprodil (3 𝜇M), an antagonist of the NR2B.
Ifenprodil did not alter either fEPSPs (ifenprodil: 𝑛 = 5; 0.5 h:
102.26±1.35%; 1 h: 104.95±3.00%; 1.5 h: 105.45±3.91%; 2 h:
103.28±4.53%; and 2.5 h: 96.99±4.15% compared to control,
see above; Figure 5) or spiking activity (𝑛 = 5; ifenprodil:
0.5 h: 127.11 ± 53.62%, 1 h: 163.58 ± 101.77%; 1.5 h: 81.37 ±
37.37%, 2 h: 110.35 ± 65.81%; and 2.5 h: 120.26 ± 64.58%;
Figure 6), suggesting that NR2B-activation is not required for
basic synaptic transmission in the CA1. However, Abeta(1-42)
induced elevated spiking activity was prevented by ifenprodil
(ifenprodil + Abeta(1-42): 𝑛 = 5; 0.5 h: 157.44 ± 84.19%; 1 h:
196.87± 79.61%; 1.5 h: 116.36± 61.71%; 2 h: 101.72± 76.26%;
and 2.5 h: 88.88 ± 59.67%, 𝑃 = 0.048, Mann-Whitney 𝑈 test
compared toAbeta(1-42), see above; Figure 6)without chang-
ing of fEPSPs amplitudes (ifenprodil + Abeta(1-42): 𝑛 = 5;
0.5 h: 100.17 ± 1.53%; 1 h: 100.57 ± 2.38%; 1.5 h: 98.85 ±
3.66%; 2 h: 95.45 ± 4.97%; and 2.5 h: 93.15 ± 5.47%; Figure 5),
suggesting that the hyperexcitability caused by Abeta(1-42)
requires the activation of extrasynaptic NR2B receptors, but
not AMPARs.
3.5. Characterization of Abeta(1-42). The size distribution of
Abeta(1-42) oligomers formed in 50 𝜇M after incubation at
37∘C was studied on Western blots by using two different
antibodies; the monoclonal BAM10 antibody is sequence
specific and binds to the N-terminal end of the peptide,
while OC stains the oligomers of fibrillar nature (protofibrils,
oligomerswith beta sheet structure) [26]. Supplementary Fig-
ure 4 shows the results of theWB experiments. BAM10 stain-
ing reveals the presence of both low- and high-molecular-
weight oligomers in the sample, while their positive staining
with the OC antibody indicates that they have protofibrillar
characteristics.Thepresence of SDS stable dimers and trimers
in the sample closely resembles Abeta(1-42) derived from
biological sources, namely, from transfected 7PA2 cells [27]
and from human brain [28, 29]. These species were shown to
have strong synaptotoxic properties [30]. On the other hand,
protofibrillar species, which are also abundant in our sample,
were also reported to be synaptotoxic [16].
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Figure 6: Abeta(1-42) induces hyperexcitation via NR2B. Abeta(1-42) induced increased spiking activity (untreated versus Abeta(1-42): 1 h:
∗
𝑃 = 0.043; 2 h: ∗𝑃 = 0.036; 2.5 h: ∗∗∗𝑃 = 0.001; Mann-Whitney 𝑈 test). Ifenprodil did not affect spontaneous activity but prevented the
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panel shows exemplar units from the respective recordings, while bottom panel illustrates representative spike trains. Error bars represent
SEM; ∗𝑃 ≤ 0.05; ∗∗∗𝑃 ≤ 0.001; #𝑃 ≤ 0.05.
4. Discussion
4.1. AMPA Receptors Regulate fEPSPs and NMDA Receptors
Mediate Spontaneous Spiking. Extracellular fEPSP recordings
are the gold standard for determining the excitation and
synaptic plasticity in hippocampal slices. The changes of
spontaneous spiking activity under conditions that modify
network excitability are, however, less well studied in acute
slices. In these sets of experiments we have studied the
involvement of AMPARs and NMDARs in fEPSPs evoked
by Schaffer-stimulation and in spontaneous firing in the
CA1. We show that these two electrophysiological markers,
previously thought to underlie measures of excitation, are
not correlated. Importantly, the spikes we recorded here
were almost exclusively localized to the pyramidal layer
of CA1; hence, they were presumably from principal cells.
Multiunit activity recordings do not allow separating the
firing from individual neurons and may include bursts
of spikes fired by the same neuron. Thus, in our study,
spiking represents the global amount of activity within this
network and most probably the activity of principal cells.
The firing rates observed in this study were comparable to
previously reported values in slices of CA1 of the guinea pig
(0.22 and 1.8 spikes/sec) [6]. Under our conditions, blocking
AMPAR with CNQX inhibited fEPSPs, however, the spiking
activity did not change. In contrast, modulating NMDAR
function affected spontaneous firing without any change in
evoked fEPSPs. Blocking NMDARs ablated, while enhancing
NMDAR function increased spontaneous activity.
4.2. Possible Involvement of the CA1 Local Microcircuitry in
the Regulation of Spontaneous Spiking. Direct comparison
of data from CA3 spiking regulation and our CA1 data is
Neural Plasticity 9
difficult, because glutamatergic pyramidal cells of the CA3
form massive recurrent loops, a feature that is missing in
the CA1. Therefore, the activity of CA1 pyramidal cells
is regulated by the excitation arriving from CA3 through
the Schaffer-collateral and by the inhibition of the local
interneuron microcircuitry. Although the activity of CA1
inhibitory cells has been reported to be scarce, compared to
CA3 in acute slices, powerful pyramidal somatic inhibition
could be detected upon minimal electric stimulation [31],
showing that the inhibition is very effective. What is the
driving force of the interneuronal activity? One possible
explanation is that the spontaneous activity of the incoming
axons of the CA3 principal cells recruits a CA1 inhibitory
microcircuitry via the Schaffer-collateral. This is unlikely,
because there is no correlation between CA3 multiunit
activity and the extracellularly recorded inhibitory postsy-
naptic potential in the CA1 [31]. Another possibility is that
the spontaneous discharge of CA1 interneurons, although
scarce, is keeping a strong blockade of the principal cells.
Favoring this hypothesis, the resting membrane potential is
more hyperpolarized in CA1 compared to CA3 pyramidal
neurons [32, 33]. These spontaneous discharges might be
regulated by the ambient Glu concentration via NMDARs.
Indeed, tonic activation of NMDARs by ambient glutamate
has been described in virtually all pyramidal cells of the CA1
of the hippocampus in slice models [34–37]. Importantly,
as Le Meur et al. have shown [38], neither AMPA/kainate
receptors normetabotropic glutamate receptors contribute to
this tonic excitation of pyramidal neurons.This tonic current
is not dependent on vesicular release of transmitters from
neurons but is affected by inhibition of the enzyme converting
Glu, in glutamine in glial cells, indicating that ambient Glu
is mainly of glial origin. Consistent with these findings,
we have also shown that spontaneous spiking is driven by
NMDAR activity, but not by AMPARs, indicating that the
tonic activation could reach the threshold of spike generation.
The question arises as follows: why do not AMPARs mediate
spontaneous activity? NMDARs have a much higher affinity
for Glu than AMPARs do; in steady-state conditions, the
EC50 for Glu at NMDARs is over two orders of magnitude
lower than that at AMPARs [39]. Extrasynaptic NMDARs
containing the NR2B subunit have even higher affinity than
synaptic NR2A-containing receptors [40]. It should be noted
that evoked firing, which is usually detected in the form of
population spikes (pop-spikes for short) in CA1 extracellular
recordings, is mediated by AMPAR signaling [41]. Under our
conditions, action potentials were not inhibited by AMPAR
blockade. The reason behind this discrepancy might be that
evoked pop-spikes require a synchronous discharge of a
population of cells.This coordinated functionmight be based
on the fast AMPAR function.
4.3. Abeta(1-42) Impairs LTP and Hyperexcites without Alter-
ing fEPSPs in the CA1 . Neuronal hyperexcitability in early
AD and in AD modeling mice is an emerging finding that
points to a network dysfunction as a critical component
of the pathomechanism. Soluble Abeta species have been
increasingly implicated as the key pathologic components of
the disease, thus elucidating the mechanisms by which these
species alter neuronal function is important. We confirmed
that the Abeta(1-42) preparationwe use is really synaptotoxic,
impairing LTP. Next we tested its effect on spontaneous
firing and found that it enhanced the rate of spontaneous
discharges but did not alter evoked fEPSPs. These results
suggest that NMDARs are involved in the hyperexcitability
induced by Abeta(1-42). Similar results have been recently
reported by Varghese et al. using cultured embryonic rat hip-
pocampal cells. Abeta increased spontaneous firing activity
dose dependently, reaching the maximum after 1 hour of
treatment, which was followed by a complete cessation of
spikes following a few hours [42]. The discrepancy between
this and our result may be due to the fact that the authors
have used a cell culture largely devoid of glial elements, while
we have used a complex microcircuitry built up from all of
the neuronal cell types (including glia) forming elaborate
connections.
The forms of NMDAR are heterotetramer including two
NR1 and two NR2 subunits [43]. One particular subunit,
NR2B, is mainly localized in extrasynaptic side. Abeta
induced elevation of spiking activity could be prevented by
blocking the NR2B subunits, suggesting that Abeta acti-
vates extrasynaptic NMDARs. The role of extrasynaptic or
perisynaptic NMDARs in Abeta(1-42)-induced changes in
functional synaptic plasticity and subsequent cell death has
received much attention recently [22, 44, 45]. Extrasynaptic
NMDARs contain predominantly NR2B subunits, which
in contrast to NR2A-containing synaptic NMDARs trigger
apoptotic signaling cascade [46]. Recently it was shown, using
organotypic hippocampal cell cultures, that Abeta induces
neuronal death and subsequent tau hyperphosporilation via
extrasynaptic NR2B subunit [47]. Blocking NR2B subunits
not only prevents hyperexcitation caused by Abeta but also
rescues Abeta induced LTP impairment [22, 48], suggesting
that blocking NR2B subunits might be a promising target
in AD. However, others have reported that Abeta oligomers
directly activate NMDARs especially via NR2A subunit [49,
50].
5. Conclusions
Taken together, we show that two electrophysiological events,
recorded from hippocampal slices, which evoked fEPSPs
and spontaneous firing, are not mediated by the same
mechanisms. Evoked fEPSPs, but not firing activity, were
mainly regulated by AMPARs. In contrast, spontaneous
spikes are governed by NMDAR function. Bath applications
of synaptotoxic Abeta(1-42) enhanced firing activity in an
NR2B-dependent manner without altering evoked fEPSPs.
These effects may contribute to synaptic dysfunctions seen in
early AD.
6. Highlights
(i) Spontaneous discharges and evoked fEPSPs were
recorded from the CA1 of murine slices.
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(ii) AMPA receptor blockade ablates fEPSPs without any
effect on spiking rate.
(iii) NMDA receptor modulation affects spontaneous
spiking, but not evoked fEPSPs.
(iv) Synaptotoxic amyloid-beta leaves evoked fEPSPs
unaltered but increases firing activity via NR2B.
(v) These results confirm that amyloid-beta induces
hyperexcitation through NR2B activation.
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